Curriculum · Public Health and Communicable Diseases
Sputum AFB smear, NAA testing and culture in pulmonary tuberculosis
What it is
The assays used in the diagnosis of active tuberculosis answer the same clinical laboratory question, are mycobacteria present in a clinical specimen, and they differ in speed, in sensitivity and in what still has to be done after them.
How it is diagnosed
Collection comes first: three sputum specimens for AFB smear microscopy and culture, at least one of them also tested using an NAA test. Sputum is preferably 3 samples including an early morning sample, induced with nebulised hypertonic saline if the patient is not expectorating.
- Acid-fast stain gives same-day results with simple, inexpensive technology. Direct microscopy of sputum is the most important first step, and the probability of detecting acid-fast bacilli is proportional to the bacillary burden, typically positive when 5000-10 000 organisms are present. Its limits are that it is less sensitive than culture, requiring 10,000 organisms/mL, and it cannot distinguish M. tuberculosis from other mycobacteria. Ziehl-Neelsen and auramine fluorescence are the stains; auramine fluorescence is more sensitive though less specific than Ziehl-Neelsen, and by fluorescence microscopy bacilli appear as yellow-orange on a green background.
- Culture on solid media (Lowenstein-Jensen egg-based or Middlebrook agar-based) is the gold standard for isolating Mycobacterium tuberculosis. It detects 10-100 organisms/mL, shows colony morphology, detects mixed infection, allows quantification of growth, and provides organisms for speciation, strain identification and susceptibility testing. Visible growth takes 3-8 wk, or 4-6 weeks. Culture in liquid broth has similar sensitivity and specificity, automated systems decrease workload, and growth is detected in 7-21 days, or 1-3 weeks, but it does not show colony morphology, detect mixed cultures or quantify growth.
- Nucleic acid amplification gives same-day results with sensitivity intermediate between acid-fast stain and culture, and identifies organisms as members of the M. tuberculosis complex. It requires advanced laboratory techniques, cannot distinguish dead from viable organisms, and culture is still needed for speciation, strain identification and susceptibility testing. GeneXpert MTB/RIF has sensitivity that nearly approximates culture, requires 100 minutes and detects rifampin resistance mutations, at the price of expensive equipment and detection of dead bacilli. PCR is only useful at the initial stage of diagnosis, since it frequently remains positive despite treatment.
- Urinary antigen detection, for example ELISA for LAM, has potential for point-of-care testing and relatively high sensitivity in advanced untreated AIDS, under 50 CD4 T cells, but sensitivity is very low in any other situation.
How it is treated
The two results are read together. If the NAA test is positive, TB disease is likely whether the AFB smear is positive or negative, and therapy for TB is initiated pending sputum culture results. If the NAA test is negative or invalid while the AFB smear is positive, TB disease is not likely and NTM disease may be present, and it is only from here that a second sputum specimen is obtained for AFB smear, culture and NAA test. If the NAA test is negative or invalid and the AFB smear is negative, TB disease is not excluded, and the decision regarding initiation of empiric therapy for TB should be made based on clinical, radiographic and epidemiologic data; no second specimen is ordered from there. The second specimen has its own four answers, and they are not the same as the first:
- NAA positive with a positive AFB smear: TB disease likely, mixed infection with NTM possible, and therapy for TB initiated pending sputum culture results.
- NAA positive with a negative AFB smear: TB disease likely, and therapy for TB initiated pending sputum culture results.
- NAA negative or invalid with a positive AFB smear: TB disease not likely, NTM infection probable, and sputum culture results awaited to guide management of NTM.
- NAA negative or invalid with a negative AFB smear: TB disease not excluded, and the decision regarding initiation of empiric therapy for TB should be made based on clinical, radiographic and epidemiologic data.